胰腺癌在线自适应立体定向体部放疗中肠道气体在不进行在线电子密度校正时对靶区及危及器官的剂量学影响
本研究纳入30例接受在线立体定向磁共振引导自适应放疗(SMART)的胰腺癌患者,比较不进行肠道气体电子密度校正(EDC)与进行EDC时的剂量体积参数差异。结果显示多数计划中EDC对靶区剂量体积参数及全部胃肠道器官D0.5 cc影响较小,但胃肠道器官Dmax、肝脏平均剂量及双肾平均剂量可能被轻微高估,脊髓Dmax可能被轻微低估。省略肠道气体EDC可缩短在线SMART治疗时间。
要点
- 不进行肠道气体EDC时,多数计划靶区剂量体积参数及全部胃肠道器官D0.5 cc受EDC影响较小。
- 不进行EDC可能轻微高估胃肠道器官Dmax、肝脏及双肾平均剂量,可能轻微低估脊髓Dmax。
- 平均治疗时间82分钟,平均EDC时间8分钟,占总体治疗时间10%。
核心结论
- 对于分次间肠道气体分布相似的患者,EDC对多数计划中全部胃肠道器官的D0.5 cc及靶区剂量体积参数影响较小。
- 省略肠道气体EDC可缩短在线SMART治疗时间。
研究设计与样本
- 研究纳入30例接受在线SMART的胰腺癌患者。
- 记录并分析各阶段治疗时间及总治疗时间。
- 采用Wilcoxon符号秩检验比较有与无肠道气体EDC时靶区及危及器官的关注剂量体积参数。
- 采用Spearman检验分析剂量学差异与肠道气体体积变化的关系。
诊断标准与关键数值
- 以p值<0.05为差异有统计学意义。
- 有与无肠道气体EDC相比,CTV(GTV)、PTV、肠管、胃、十二指肠及皮肤的剂量体积参数差异无统计学意义(p>0.05)。
- 有与无EDC相比,胃肠道器官Dmax(p=0.03)、肝脏平均剂量(p=0.002)、左肾平均剂量(p=0.03)及右肾平均剂量(p=0.04)可能存在轻微高估风险。
- 有与无EDC相比,脊髓Dmax(p=0.02)可能存在轻微低估风险。
- PTV的D95与十二指肠的D0.5 cc观察到弱相关。
临床应用与阅片要点
- 对于分次间肠道气体分布相似的患者,不进行肠道气体EDC时多数计划靶区剂量体积参数及全部胃肠道器官D0.5 cc受EDC影响较小。
- 不进行EDC时需注意胃肠道器官Dmax、肝脏及双肾平均剂量可能被轻微高估,脊髓Dmax可能被轻微低估。
- 省略肠道气体EDC可缩短在线SMART治疗时间,平均EDC时间8分钟,占总体治疗时间10%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aimed to assess the dosimetric effect of intestinal gas of stereotactic magnetic resonance (MR)-guided adaptive radiation therapy (SMART) on target and critical organs for pancreatic cancer without online electron density correction (EDC).
METHODS: Thirty pancreatic cancer patients who underwent online SMART were selected for this study. The treatment time of each stage and the total treatment time were recorded and analyzed. The concerned dose-volume parameters of target and organs-at-risk (OAR) were compared with and without an intestinal gas EDC using the Wilcoxon-signed rank test. Analysis items with p value < 0.05 were considered statistically significant. The relationships between dosimetric differences and intestinal gas volume variations were investigated using the Spearman test.
RESULTS: The average treatment time was 82 min, and the average EDC time was 8 min, which accounted for 10% of the overall treatment time. There were no significant differences in CTV (GTV), PTV, bowel, stomach, duodenum, and skin (p > 0.05) with respect to dose volume parameters. For the Dmax of gastrointestinal organs (p = 0.03), the mean dose of the liver (p = 0.002) and kidneys (p = 0.03 and p = 0.04 for the left and right kidneys, respectively), there may be a risk of slight overestimation compared with EDC, and for the Dmax of the spinal cord (p = 0.02), there may be a risk of slight underestimation compared with EDC. A weak correlation for D95 in the PTV and D0.5 cc in the duodenum was observed.
CONCLUSION: For patients with similar inter-fractional intestinal gas distribution, EDC had little dosimetric effects on the D0.5 cc of all GI organs and dose volume parameters of target in most plans.
ADVANCES IN KNOWLEDGE: By omitting the EDC of intestinal gas, the online SMART treatment time can be shortened.
引用
- Su C, Okamoto H, Nishioka S, et al. Dosimetric effect of the intestinal gas of online adaptive stereotactic body radiotherapy on target and critical organs without online electron density correction for pancreatic cancer. Br J Radiol. 2021. PMID: 33353402. doi:10.1259/bjr.20200239
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。